Oracle Corporation finds itself at a financial crossroads, with its upcoming quarterly earnings release on December 10th drawing sharply divided opinions from Wall Street. Following a severe November decline that saw its shares lose over 20% of their value, the market is questioning whether this represents a compelling buying opportunity or a stark warning sign.
Divergent Analyst Views Highlight Uncertainty
The spectrum of analyst sentiment is remarkably wide. On the bullish end, HSBC reiterated a “Buy” rating on December 3rd, attaching a price target of $382—nearly double the current trading level. The British investment bank’s analysts position Oracle as a stealth contender in the cloud infrastructure battle against Amazon Web Services (AWS) and Microsoft Azure, citing over a decade of strategic planning to capture market share. They highlight Oracle’s contractual backlog, known as Remaining Performance Obligations (RPO), which now exceeds $500 billion. HSBC expresses confidence that the company can manage its massive data center expansion without jeopardizing its investment-grade credit rating, partly through strategic joint ventures and special purpose entities.
This optimism is not universally shared. DA Davidson recently adopted a more cautious stance, reducing its price target from $300 to $200. The firm cites concerns over Oracle’s significant reliance on contracts with OpenAI and growing credit risks as primary reasons for its tempered outlook.
Strategic Bets and Partnerships Under Scrutiny
Oracle’s deep involvement with OpenAI remains a central debate. As noted by Deutsche Bank, the market appears to be assigning “little to no recognition” to this business relationship. Key investor questions focus on the timeline for these multibillion-dollar AI contracts to materially contribute to earnings and their ultimate profitability profile.
Should investors sell immediately? Or is it worth buying Oracle?
Concurrently, Oracle is advancing its multi-cloud strategy. In early December, the company announced an expanded partnership with Amazon Web Services. This collaboration enables customers to centrally manage encryption keys for Exadata databases via the AWS platform, a significant move for meeting compliance demands and supporting hybrid cloud architectures.
Key Metrics for the December 10th Report
When Oracle reports after the U.S. market close on Wednesday, investor focus will zero in on several critical areas:
- Cloud Revenue Momentum: Cloud revenue grew by 28% in the first quarter; the key question is whether Oracle can sustain this pace.
- RPO Trajectory: Contractual commitments surged by 359% in the prior quarter to $455 billion. Any further expansion will be closely watched.
- OpenAI Clarity: Updates on the schedule and profit dynamics of the AI agreements are highly anticipated.
- Leverage and Financing: The market seeks details on how Oracle intends to fund its aggressive infrastructure push without overextending its balance sheet.
The current analyst consensus forecasts earnings per share of $6.81 for fiscal year 2026, representing growth of nearly 13%. The average price target among 43 covering analysts stands at approximately $325, implying potential upside of over 60% from recent levels.
Lofty Targets Justify the Premium Valuation
Oracle’s leadership has set ambitious goals, placing the company under pressure to execute. Management is targeting OCI (Oracle Cloud Infrastructure) revenue of $18 billion by 2026, with a long-term ambition of reaching $144 billion by 2030. Success in this transformative effort could justify the current valuation of nearly 30 times forward earnings. Should the company falter, however, shares may face further downward pressure. The December report will provide crucial evidence on which path lies ahead.
Ad
Oracle Stock: Buy or Sell?! New Oracle Analysis from December 3 delivers the answer:
The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 3.
Oracle: Buy or sell? Read more here...









